Dawnrays Pharmaceutical (Holdings) Limited (2348.HK)

HKD 1.16

(0.87%)

EBITDA Summary of Dawnrays Pharmaceutical (Holdings) Limited

  • Dawnrays Pharmaceutical (Holdings) Limited's latest annual EBITDA in 2023 was 498.93 Million CNY , up 5.38% from previous year.
  • Dawnrays Pharmaceutical (Holdings) Limited's latest quarterly EBITDA in 2023 FY was N/A , up 5.38% from previous quarter.
  • Dawnrays Pharmaceutical (Holdings) Limited reported an annual EBITDA of 505.18 Million CNY in 2022, up 8.55% from previous year.
  • Dawnrays Pharmaceutical (Holdings) Limited reported an annual EBITDA of 433.88 Million CNY in 2021, up 16.29% from previous year.
  • Dawnrays Pharmaceutical (Holdings) Limited reported a quarterly EBITDA of 251.93 Million CNY for 2023 Q2, down 0.0% from previous quarter.
  • Dawnrays Pharmaceutical (Holdings) Limited reported a quarterly EBITDA of 102.49 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Dawnrays Pharmaceutical (Holdings) Limited (2023 - 2002)

Historical Annual EBITDA of Dawnrays Pharmaceutical (Holdings) Limited (2023 - 2002)

Year EBITDA EBITDA Growth
2023 498.93 Million CNY 5.38%
2022 505.18 Million CNY 8.55%
2021 433.88 Million CNY 16.29%
2020 395.71 Million CNY 9.22%
2019 341.58 Million CNY -13.75%
2018 430.55 Million CNY 0.51%
2017 418.36 Million CNY 9.14%
2016 386.27 Million CNY -9.85%
2015 432.82 Million CNY 38.82%
2014 308.14 Million CNY 37.48%
2013 227.98 Million CNY 18.35%
2012 178.29 Million CNY -15.55%
2011 209.94 Million CNY -10.88%
2010 235.56 Million CNY 32.38%
2009 177.94 Million CNY 27.09%
2008 140.01 Million CNY 6.66%
2007 131.27 Million CNY 45.27%
2006 90.36 Million CNY -25.87%
2005 121.9 Million CNY 25.48%
2004 97.15 Million CNY -18.08%
2003 118.59 Million CNY 12.12%
2002 105.77 Million CNY 0.0%

Peer EBITDA Comparison of Dawnrays Pharmaceutical (Holdings) Limited

Name EBITDA EBITDA Difference
Pak Fah Yeow International Limited 150.4 Million HKD -231.741%
Grand Pharmaceutical Group Limited 2.96 Billion HKD 83.181%
Extrawell Pharmaceutical Holdings Limited -129.51 Million HKD 485.222%
Wai Yuen Tong Medicine Holdings Limited 113.79 Million HKD -338.443%
Qianhai Health Holdings Limited -50.22 Million HKD 1093.329%
Lee's Pharmaceutical Holdings Limited 109.82 Million HKD -354.324%
Essex Bio-Technology Limited 418.37 Million HKD -19.256%
Tongfang Kontafarma Holdings Limited 76.63 Million HKD -551.076%
PuraPharm Corporation Limited -26.16 Million HKD 2006.603%
SSY Group Limited 2.11 Billion HKD 76.405%
JBM (Healthcare) Limited 204.39 Million HKD -144.111%
Jacobson Pharma Corporation Limited 429.92 Million HKD -16.054%
China Resources Pharmaceutical Group Limited 15.43 Billion HKD 96.767%